Presidio Property Trust, Inc.

Listed Company

SQFTPCIK 0001080657NasdaqNon-AcceleratedSmaller ReportingReal Estate Investment TrustsMarylandFY ends Dec 31

Period

FY 2025

Revenue

$16.81M

Net Income

$-8.28M

Total Assets

$122.05M

Equity

$16.84M

Shares Out

1.44M

Op. Cash Flow

$417.9K

Business

Presidio Property Trust, Inc. is an internally-managed real estate investment trust that acquires, owns, manages and leases commercial properties and model homes. It offers leasing of office and industrial space, sale‑leaseback (triple‑net) model homes to homebuilders, property management, and advisory services for affiliated partnerships. Its operations are organized around two principal businesses: Office/Industrial Properties and PPT Model Homes, supported by DownREITs, limited partnerships and a wholly owned model home corporation. The company operates properties in Colorado, North Dakota, California, Maryland and Texas, with model homes in Texas, Florida and Arizona, and distributes space through direct leasing, affiliated partnerships and third‑party property managers.

Summary from filing dated 2025-03-31

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Rental income	16	19	17	17	18
Fees and other income	343,790	401,462	243,217	560,971	810,852
Total revenue	17	19	18	18	19
Rental operating costs	6	6	6	6	6
General and administrative	6	8	7	6	6
Depreciation and amortization	5	6	5	6	5
Asset Impairment Charges	6	2	3	0	—
Total costs and expenses	23	21	21	—	—
Interest and other income, net	20,881	−151,356	1	21,075	−42,845
Gain on sales of real estate, net	5	3	3	—	—
Net loss in Conduit Pharmaceuticals marketable securities (see footnote 9)	−188,287	−18	−23	—	—
Income tax (expense) benefit	−463,170	−60,855	335,780	−1	47,620
Total loss, net	−1	−21	17	1	−2
Net loss:	−8	−23	13	1	−1
Less: Income attributable to noncontrolling interests	−685,586	−3	−3	−4	−2
Net loss attributable to Presidio Property Trust, Inc. stockholders	−8	−26	10	−2	−4
Less: Preferred Stock Series D dividends	−2	−2	−2	−2	−1
Net loss attributable to Presidio Property Trust, Inc. common stockholders	−11	−28	8	−7	−5
Basic & Diluted (in dollars per share)	−8.65	−22.5	0.68	−0.57	−0.46
Weighted average number of common shares outstanding - basic & dilutive (in shares)	1	1	12	12	10

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Land	16	16	22	19	21
Buildings and improvements	102	103	134	126	119
Tenant improvements	18	16	18	14	13
Lease intangibles	3	4	4	4	4
Real estate assets and lease intangibles held for investment, cost	139	139	177	163	157
Accumulated depreciation and amortization	−38	−34	−39	−35	−31
Real estate assets and lease intangibles held for investment, net	102	105	139	128	127
Real estate assets held for sale, net	7	22	5	2	11
Real estate assets, net	109	128	144	131	138
Cash, cash equivalents and restricted cash	7	8	7	17	15
Deferred leasing costs, net	1	2	2	2	1
Goodwill	1	1	2	2	2
Investment in Conduit Pharmaceuticals marketable securities (see Notes 2 & 9)	3,900	206,177	18	0	—
Deferred tax asset	223,388	298,645	346,762	0	—
Other Assets, Miscellaneous	3	3	3	4	5
Total other assets	13	15	32	24	23
TOTAL ASSETS	122	143	176	291	161
Mortgage notes payable, net	82	81	104	96	87
Mortgage notes payable related to properties held for sale, net	10	21	4	999,523	2
Mortgage notes payable, total net	92	102	108	97	89
Accounts payable and accrued liabilities	3	3	5	4	5
Accrued real estate taxes	2	2	2	2	2
Dividends payable - Preferred Stock Series D	190,220	194,784	174,011	178,511	179,685
Lease liability, net	40,108	64,345	16,086	46,833	75,547
Below-market leases, net	3,316	8,625	13,266	18,240	73,130
Total liabilities	97	108	115	108	96
Commitments and contingencies (see Note 10)	—	—	—	—	—
Additional paid-in capital	187	186	182	182	186
Dividends and accumulated losses	−170	−159	−132	−138	−131
Total stockholders' equity before noncontrolling interest	17	27	51	44	56
Noncontrolling interest	8	8	10	9	10
Total equity	25	35	61	53	65
TOTAL LIABILITIES AND EQUITY	122	143	176	291	161

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	5	6	—	—	—
Stock compensation	1	1	989,515	1	2
Employee Bonuses paid with CDT stock	0	172,421	0	—	—
Amortization of financing costs	281,245	351,291	345,880	240,090	479,853
Amortization of below-market leases	−4,753	−4,641	−4,974	−54,890	−60,203
Straight-line rent adjustment	261,483	−152,722	−332,055	−252,759	−231,577
Other assets	355,913	82,575	−211,023	1	190,354
Deferred tax asset	75,257	48,117	−346,762	0	—
Accounts payable and accrued liabilities	186,636	−1	11,546	−2	−1
Deferred leasing costs	−148,148	−502,946	—	—	—
Accrued real estate taxes	−187,448	19,390	73,212	−61,038	−607,773
Net cash provided by (used in) operating activities	417,870	−728,060	1	928,817	2
Real estate acquisitions	−9	−10	−22	−16	−22
Additions to buildings and tenant improvements	−3	−2	−6	−2	−2
Investment in marketable securities	0	−2,362	−2	−2	−4
Proceeds from sale of marketable securities	13,990	105,206	3	2	2
Proceeds from sales of real estate, net	26	25	11	26	50
Net cash provided by investing activities	13	13	121	−126	24
Proceeds from mortgage notes payable, net of issuance costs	19	22	21	20	12
Payment of debt issuance costs	−424,002	−335,724	−246,557	−3	−572,458
Repayment of mortgage notes payable	−29	−28	−10	−12	−43
Payment of deferred offering costs	−343,514	0	−5,000	—	—
Distributions to noncontrolling interests	−1	−4	−4	—	—
Contributions from noncontrolling interests	0	200,000	3	—	—
Dividends paid to Series D Preferred Stockholders	−2	−2	−2	−2	−994,263
Net cash used in financing activities	−15	−11	−132	127	−23
Net (decrease) increase in cash equivalents and restricted cash	−614,137	2	−10	2	3
Income taxes paid	78,848	46,511	533,340	—	—
Paid building and tenant improvements from prior year	−207,847	−295,567	—	—	—
Private warrants from Conduit Pharmaceuticals	0	642,600	0	—	—
Unpaid deferred offering costs	6,589	0	—	0	15,449
Unpaid building and tenant improvements	361,261	207,847	295,567	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro